Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells

Biochemical and Biophysical Research Communications

Volumn 407, Issue 3, 2011, Pages 575-580

  Liu, Yi Hsiang ^a,b   Ho, Chin Chin ^c   Cheng, Chiung Chi ^a   Chao, Wei Ting ^d   Pei, Ren Jeng ^e   Hsu, Yung Hsiang ^b   Lai, Yih Shyong ^a  

^a CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Yongsin Pathological Center   (Taiwan)

Author keywords

Cytokeratin; Cytoskeleton; Hepatocellular carcinoma; Plectin; Staurosporine; Transformation

Indexed keywords

ACTIN; CYTOKERATIN 18; PLECTIN; STAUROSPORINE; TUBULIN;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CYTOSKELETON; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMEDIATE FILAMENT; LIVER CELL; LIVER CELL CARCINOMA; MICROFILAMENT; MICROTUBULE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEGRADATION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; HEPATOCYTES; HUMANS; INTERMEDIATE FILAMENTS; KERATIN-18; LIVER NEOPLASMS; PLECTIN; STAUROSPORINE;

EID: 79954613064     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.066     Document Type: Article

References (26)

1. Feldmann G. The cytoskeleton of the hepatocyte. Structure and functions. J. Hepatol. 1989, 8:380-386.
2. Fuchs E., Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science (New York, NY) 1998, 279:514-519.
3. Van Eyken P., Desmet V.J. Cytokeratins and the liver. Liver 1993, 13:113-122.
4. Volkmann N., DeRosier D., Matsudaira P., Hanein D. An atomic model of actin filaments cross-linked by fimbrin and its implications for bundle assembly and function. J. Cell Biol. 2001, 153:947-956.
5. Nogales E. Structural insights into microtubule function. Annu. Rev. Biochem. 2000, 69:277-302.
6. Rezniczek G.A., Janda L., Wiche G. Plectin. Methods Cell Biol. 2004, 78:721-755.
7. Kazerounian S., Uitto J., Aho S. Unique role for the periplakin tail in intermediate filament association: specific binding to keratin 8 and vimentin. Exp. Dermatol. 2002, 11:428-438.
8. Wiche G. Role of plectin in cytoskeleton organization and dynamics. J. Cell Sci. 1998, 111(Pt. 17):2477-2486.
9. Schröder R., Kunz W.S., Rouan F., et al. Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy. J. Neuropathol. Exp. Neurol. 2002, 61:520-530.
10. Su B., Pei R.J., Yeh K.T., et al. Could the cytokeratin molecule be modulated during tumor transformation in hepatocellular carcinoma?. Pathobiology 1994, 62:155-159.
11. Cheng C.C., Liu Y.H., Ho C.C., et al. The influence of plectin deficiency on stability of cytokeratin18 in hepatocellular carcinoma. J. Mol. Histol. 2008, 39:209-216.
12. Liu Y.H., Cheng C.C., Ho C.C., et al. Plectin deficiency on cytoskeletal disorganization and transformation of human liver cells in vitro. Med. Mol. Morphol. 2011, 44:21-26.
13. Stegh A.H., Herrmann H., Lampel S., et al. Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol. Cell. Biol. 2000, 20:5665-5679.
14. Aho S. Plakin proteins are coordinately cleaved during apoptosis but preferentially through the action of different caspases. Exp. Dermatol. 2004, 13:700-707.
15. Schutte B., Henfling M., Kolgen W., et al. Keratin 8/18 breakdown and reorganization during apoptosis. Exp. Cell Res. 2004, 297:11-26.
16. Jordà E.G., Verdaguer E., Jimenez A., et al. Evaluation of the neuronal apoptotic pathways involved in cytoskeletal disruption-induced apoptosis. Biochem. Pharmacol. 2005, 70:470-480.
17. Liu Y.H., Cheng C.C., Ho C.C., et al. Degradation of plectin with modulation of cytokeratin 18 in human liver cells during staurosporine-induced apoptosis. In Vivo 2008, 22:543-548.
18. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981, 29:577-580.
19. Reuner K.H., Dunker P., van der Does A., Wiederhold M., Just I., Aktories K., Katz N. Regulation of actin synthesis in rat hepatocytes by cytoskeletal rearrangements. Eur. J. Cell Biol. 1996, 69:189-196.
20. Katsuma Y., Marceau N., Ohta M., French S.W. Cytokeratin intermediate filaments of rat hepatocytes: different cytoskeletal domains and their three dimensional structure. Hepatology 1988, 8:559-568.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Crowe D.L., Milo G.E., Shuler C.F. Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potential. J. Dent. Res. 1999, 78:1256-1263.
23. Asch H.L., Head K., Dong Y., et al. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res. 1996, 56:4841-4845.
24. Dandachi N., Hauser-Kronberger C., More E., et al. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J. Pathol. 2001, 193:181-189.
25. Chakraborty J., Von Stein G.A. Pleomorphism of human prostatic cancer cells (DU 145) in culture-the role of cytoskeleton. Exp. Mol. Pathol. 1986, 44:235-245.
26. Muenchbach M., Dell'Ambrogio M., Gazzotti P. Proteolysis of liver plectin by mu-calpain. Biochem. Biophys. Res. Commun. 1998, 249:304-306.